Data presented at the 2018 EuroEcho-Imaging congress in Milan suggest breast cancer patients who take the common chemo drug trastuzumab might be able to mitigate their risk of heart damage by supplementing with carvedilol, a beta-blocker used predominantly by cardiac patients.

Individuals who live in greener neighborhoods might be less likely to develop heart disease and stroke than those residing in areas with fewer parks or green spaces, according to a Journal of the American Heart Association study published Dec. 5.

A little weight lifting can have a big impact on heart health, even in the absence of aerobic endurance training, according to recent research in Medicine & Science in Sports & Exercise.

The authors of a new study in the Annals of Internal Medicine believe too many patients are being recommended statin therapy, and contend that current guidelines don’t fully consider the risks of the popular drugs.

Home telemonitoring approaches for heart failure patients are associated with lower odds of death at six months but not beyond that, according to a meta-analysis published in the December issue of Health Affairs.

It takes emergency medical services (EMS) almost four minutes longer to transport cardiac arrest patients from poor neighborhoods to the hospital versus those from high-income neighborhoods, according to a study of 2014 United States EMS data published in JAMA Network Open.

Seniors taking five or more prescription drugs to treat heart failure could be at an increased risk for functional impairment, according to a study published in the Journal of the American Geriatrics Society.

BTG plc (LSE: BTG), the global healthcare company, today announced the first patients outside of a clinical trial have been successfully implanted with the BTG Sentry device – the world’s first bioconvertible IVC filter.